Straumann distinguished as a ‘Most Honored Company’ in All-Europe Executive Team survey published by Institutional Investor
Basel, 6 April 2017 - Straumann Holding AG has been nominated as one of Europe’s Most Honored Companies in the 2017 rankings published by Institutional Investor .
Each year Institutional Investor conducts a survey among approximately 2600 financial analysts to identify Europe’s best CEOs, CFOs, IROs, Investor Relations programs and companies. The award comes from the journal’s research program, which captures the views of top investment portfolio managers and analysts including its own research team. It is thus an objective, independent, assessment by a representative section of the financial industry.
A total of 2961 companies across Europe received votes in this year’s All-Europe Executive Team survey. Of these, 109 were distinguished in the full sector for their corporate leadership and investor relations expertise. 1264 companies were named in the magazine’s inaugural small- and mid-cap company ranking, of which 31 were recognized as Europe’s Most Honored Companies for having ranked at the top across multiple leadership categories.
Companies are distinguished as ‘Most Honored’ for receiving two or more first-, second-, or third-place rankings in one or more of the categories: Best CEO, CFO, IR professional and IR program. Straumann was distinguished in the full sector ranking and was the highest ranking Medtech company in the small- and mid-cap companies. The Group is one of just 10 Swiss companies to be recognized this year alongside heavyweights like ABB, Nestlé, Novartis and Roche, which have considerably larger IR capabilities.
About Institutional Investor
Institutional Investor is one of the world’s foremost financial publications.It publishes global research and issues rankings throughout the year that often serve as industry benchmarks. Top-line results are published in the magazine while the full details are available on institutionalinvestor.com.
The Straumann Group (SIX: STMN) is a global leader in tooth replacement solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in tooth replacement and esthetics, including Straumann, Instradent, Neodent, and Medentika, etkon and other fully/partly owned companies and partners.
In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.
Headquartered in Basel, Switzerland, the Group employs 3800 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.